Hypertension, Portal: all 345 studies

Page 2 of 4. Open to participants first (110), then studies with results posted, then the rest; newest registration first within each.

• EUS Guided Portal-systemic Pressure Gradient MeasurementRecruitingNCT04633356Phase 1/2
• Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver DiseaseRecruitingNCT04578301
• Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2)RecruitingNCT04393519
• Ivabradine in Cirrhotic CardiomyopathyRecruitingNCT04111133Not applicable
• Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and LactuloseRecruitingNCT04073290Phase 4
• Vienna Vascular Liver Disease StudyRecruitingNCT03541057
• Austrian Registry on Transjugular Intrahepatic Portosystemic ShuntsRecruitingNCT03409263
• VICIS - Vienna Cirrhosis StudyRecruitingNCT03267615
• Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver CirrhosisNot yet recruitingNCT03130127Not applicable
• Natural History of Noncirrhotic Portal HypertensionRecruitingNCT02417740
• A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the BellyTerminatedNCT06082843Phase 2Results posted
• NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis PatientsTerminatedNCT06000748Phase 2/3Results posted
• A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis PatientsCompletedNCT05928624Not applicableResults posted
• LiveSMART Trial to Prevent Falls in Patients With CirrhosisCompletedNCT05794555Phase 3Results posted
• Achieving Portal Access With Scorpion Post-Approval Study (APASS)TerminatedNCT05765253Not applicableResults posted
• A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)TerminatedNCT05282121Phase 2Results posted
• A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)TerminatedNCT05161481Phase 2Results posted
• Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantTerminatedNCT05027425Phase 2Results posted
• Velacur by Sonic Incytes for Portal HypertensionCompletedNCT04576897Not applicableResults posted
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH CirrhosisTerminatedNCT04365868Phase 2/3Results posted
• Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14CompletedNCT03439189Results posted
• Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver StiffnessTerminatedNCT03352882Not applicableResults posted
• PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)CompletedNCT03175731Phase 4Results posted
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal HypertensionCompletedNCT02960204Phase 2Results posted
• A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal HypertensionTerminatedNCT02929407Phase 1Results posted
• Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic PatientsCompletedNCT02802228Phase 2Results posted
• A Physical Activity Program in End-state Liver DiseaseCompletedNCT02776553Not applicableResults posted
• Noninvasive Subharmonic Aided Pressure Estimation of Portal HypertensionCompletedNCT02489045Phase 4Results posted
• Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash CirrhosisCompletedNCT02462967Phase 2Results posted
• A Study of IDN-6556 in Cirrhotic Subjects With Portal HypertensionCompletedNCT02230683Phase 2Results posted
• Assessing Portal Hypertension With Methacetin Breath TestCompletedNCT02143778Not applicableResults posted
• The Effect of Sorafenib on Portal PressureCompletedNCT01714609Phase 2Results posted
• Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver DecompensationCompletedNCT01687257Phase 2Results posted
• An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal HypertensionCompletedNCT01640964Phase 2Results posted
• Probiotics for Liver Cirrhosis With Portal HypertensionCompletedNCT01598064Not applicableResults posted
• Early TIPS for Ascites StudyTerminatedNCT01236339Not applicableResults posted
• Efficacy and Safety of Cobiprostone in Patients With Portal HypertensionTerminatedNCT00737594Phase 2Results posted
• Percutaneous Portal Vein Recanalization for Refractory Portal Hypertension in Children With Non-Cirrhotic Extrahepatic Portal Vein ObstructionActive, not recruitingNCT07873021
• Clinical Outcomes in Patients Presenting With Acute Variceal BleedingCompletedNCT07870850
• Effect of LSD on Renal Function in Cirrhotic Patients With Portal HypertensionCompletedNCT07811713
• Effect of LSD on Lipid Profiles Within 1 Year Postoperatively in Cirrhosis Patients With Portal Hypertension BleedingCompletedNCT07811700
• Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient MeasurementCompletedNCT07703540
• Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver CirrhosisCompletedNCT07459972Phase 4
• Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic PatientsCompletedNCT07397481Phase 4
• Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical OutcomesCompletedNCT07252570
• LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary StudyActive, not recruitingNCT07140120
• Effectiveness of Treatments for Cirrhosis With Varicose VeinsActive, not recruitingNCT06961474
• Achieving Portal Access With Scorpion Post-Approval Study 2CompletedNCT06856655
• Colonic Polypectomy in Cirrhotic Patients With Portal HypertensionCompletedNCT06832826
• The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal HypertensionStatus unknownNCT06473493Phase 2/3
• Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal BleedingCompletedNCT06437964Not applicable
• Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal HypertensionCompletedNCT06245798
• Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient MeasurementsCompletedNCT06216509Not applicable
• Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLDStatus unknownNCT06144437
• Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in IndiaStatus unknownNCT06054451
• The Impact of Carvedilol Posology on Clinically Significant Portal HypertensionCompletedNCT06015373Not applicable
• A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in CirrhosisActive, not recruitingNCT05979935
• Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.Active, not recruitingNCT05872698Phase 4
• Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.CompletedNCT05767229Not applicable
• Portal Hypertension Using Magnetic Resonance ElastographyCompletedNCT05749198
• Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular DisorderStatus unknownNCT05719857Not applicable
• The BD Liverty™ TIPS Stent Graft StudyActive, not recruitingNCT05711316Not applicable
• EUS-PPG vs HVPG in Portal HypertensionCompletedNCT05689268Not applicable
• Portal Hypetension and Bariatric Surgery (BARIAPORTAL)CompletedNCT05653115
• Carvedilol vs. Propranolol in Second Prophylaxis of Variceal BleedingStatus unknownNCT05651789Not applicable
• Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics TechnologyStatus unknownNCT05551884
• Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric VaricesStatus unknownNCT05515861Not applicable
• Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled TrialStatus unknownNCT05483894Phase 2
• Hepatectomy for Early-stage HCC Patients With CSPHCompletedNCT05402644
• An AI Model Based on Smartphone-derived Multimodality Images to Evaluate Portal Hypertension in Patients With Cirrhosis (CHESS2203)Status unknownNCT05402410
• Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal DisconnectionCompletedNCT05304455Not applicable
• A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)Status unknownNCT05251272
• Vonoprazan Efficacy to Prevent Post Variceal Band Ligation UlcerCompletedNCT05227833Phase 3
• EUS vs TJ for Liver Biopsy and Portal Pressure Gradient MeasurementCompletedNCT05118308Not applicable
• Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver DiseaseCompletedNCT05107271
• Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)CompletedNCT05100485
• Ultrasound Guided Microwave Ablation of Splenomegaly in ChildrenStatus unknownNCT05050994Not applicable
• Myocardial Fibrosis and Inflammation in Liver CirrhosisCompletedNCT05047029
• Multiparametric Cardio-hepatic MRI in Patients With Noncirrhotic Portal HypertensionStatus unknownNCT05041452
• Pre-emptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cystic Fibrosis Related Liver DiseaseCompletedNCT05037643Not applicable
• Extension Study of Carvedilol RCT StudyStatus unknownNCT05021406Not applicable
• Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal HypertensionCompletedNCT04994548
• Impact of Splenic Artery Ligation in LDLT for Patients With Portal HypertensionStatus unknownNCT04988100Not applicable
• Timing of Endoscopy for Acute Variceal Bleeding in Patients With CirrhosisCompletedNCT04957875
• The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in CirrhosisStatus unknownNCT04932200
• Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Active, not recruitingNCT04863703
• Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With ShuntCompletedNCT04828369
• Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal HypertensionCompletedNCT04807803Not applicable
• Effect of Antiviral Therapy on HVPG in Patients With Viral CirrhosisStatus unknownNCT04797910
• The vPPG-detecting Software Guided Management of Cirrhotic Portal HypertensionStatus unknownNCT04786782
• SHAPE of Portal Hypertension in ChildrenCompletedNCT04720456Phase 2
• EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal HypertensionStatus unknownNCT04692805Not applicable
• Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient MeasurementsCompletedNCT04668664
• Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）CompletedNCT04645550Phase 4
• TIPS Combined With Microwave Ablation in HCC Patients With Refractory AscitesStatus unknownNCT04640116Not applicable
• Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)Status unknownNCT04639323
• To Describe the Clinical, Endoscopic and Endoscopic Ultrasound Features of Non-bleeding and Bleeding Rectal Varices, Among Patients With Portal HypertensionStatus unknownNCT04535440
• Gastroesophageal Varices in CavernomaStatus unknownNCT04525768
• Oxaliplatin-induced Portal HypertensionStatus unknownNCT04524676Not applicable
• Early Diagnosis of Oxaliplatin-induced Portal HypertensionStatus unknownNCT04524650

← Hypertension, Portal overview